Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

Author： Azziz R.   Ehrmann D.A.   Legro R.S.   Fereshetian A.G.   O'Keefe M.   Ghazzi M.N.   PCOS/Troglitazone Study Group  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.79, Iss.4, 2003-04, pp. : 932-937

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome

By Kahsar-Miller M.   Azziz R.   Feingold E.   Witchel S.F.  

Fertility and Sterility, Vol. 74, Iss. 6, 2000-12 ,pp. : 1237-1240

Elsevier

Access to resources Recommend Favorite

Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess

By Moran C.   Reyna R.   Boots L.S.   Azziz R.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 126-131

Elsevier

Access to resources Recommend Favorite

Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome

By Ciampelli M.   Guido M.   Cucinelli F.   Cinque B.   Barini A.   Lanzone A.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 712-717

Elsevier

Access to resources Recommend Favorite

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome

By Kolodziejczyk B.   Duleba A.J.   Spaczynski R.Z.   Pawelczyk L.  

Fertility and Sterility, Vol. 73, Iss. 6, 2000-06 ,pp. : 1149-1154

Elsevier

Access to resources Recommend Favorite

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome

By Winters S.J.   Talbott E.   Guzick D.S.   Zborowski J.   McHugh K.P.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 724-729

Elsevier

Access to resources Recommend Favorite